{"id":"W2047528221","doi":"10.1007/s10637-010-9611-3","title":"A phase I/II study of the Src inhibitor saracatinib (AZD0530) in combination with gemcitabine in advanced pancreatic cancer","year":2010,"lang":"en","type":"article","venue":"Investigational New Drugs","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"ca_institutions":"Ottawa Hospital; Essar Steel Algoma (Canada); BC Cancer Agency; University of Ottawa; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Gemcitabine; Internal medicine; Pancreatic cancer; Clinical endpoint; Oncology; Progressive disease; Phases of clinical research; Stage (stratigraphy); Deoxycytidine; Cancer; Chemotherapy; Clinical trial; Gastroenterology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001598104,0.001637259,0.002858205,0.0007894281,0.0005484599,0.001322284,0.0009625683,0.001366951,0.003266637],"category_scores_gemma":[0.0007803772,0.000907433,0.001899939,0.0007328881,0.001444102,0.001400915,0.0004315455,0.004258696,0.0009305577],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001092283,"about_ca_system_score_gemma":0.001799132,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001479538,"about_ca_topic_score_gemma":0.004960762,"domain_scores_codex":[0.9995769,0.000192121,0.00002247678,0.00007110728,0.00003636976,0.0001010287],"domain_scores_gemma":[0.999433,0.00009090701,0.00007666667,0.00005839945,0.00002858174,0.0003125127],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6804173,0.1291572,0.005633905,0.001274803,0.002129514,0.0005293061,0.0004187388,0.005531215,0.0513105,0.0006206513,0.006053152,0.1169237],"study_design_scores_gemma":[0.543148,0.4389701,0.007720801,0.000037643,0.0006627146,0.0003504401,0.0001103607,0.001612229,0.003995608,0.0002532857,0.003094486,0.00004438361],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9908059,0.003005553,0.000510981,0.0007249038,0.0002316134,0.001860602,0.0009398477,0.0001021973,0.001818382],"genre_scores_gemma":[0.9849336,0.005020354,0.001912964,0.0008830995,0.0002280154,0.001778094,0.002211838,0.00004609449,0.002985958],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003266637,"threshold_uncertainty_score":0.01092798,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02456104693955328,"score_gpt":0.3483358976497588,"score_spread":0.3237748507102055,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}